<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04257240</url>
  </required_header>
  <id_info>
    <org_study_id>liver IR</org_study_id>
    <nct_id>NCT04257240</nct_id>
  </id_info>
  <brief_title>Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury</brief_title>
  <acronym>annie-liver</acronym>
  <official_title>Does Vascular Occlusion in Liver Resections Predispose to Recurrence of Malignancy in the Liver Remnant Due to Ischemia/Reperfusion Injury?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aretaieion University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aretaieion University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe ischemic changes of the liver remnant after hepatectomy could expedite tumor
      recurrence on the residual liver. Our study aimed at assessing the effect of warm
      ischemic/reperfusion (I/R) injuries on surgery-to-local recurrence interval and patient
      overall survival, during major hepatectomies under inflow and outflow vascular control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred and eighteen patients were subjected to liver resection under total inflow and
      outflow vascular clamping and were assigned as study group. These individuals were
      retrospectively matched to 112 counterparts, who underwent liver surgery applying inflow and
      outflow vascular clamping only of the segment harboring the tumor, sparing the liver remnant
      from any I/R injury (control group). The two cohorts were compared regarding recurrence-free
      survival and overall survival.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2000</start_date>
  <completion_date type="Actual">December 31, 2012</completion_date>
  <primary_completion_date type="Actual">December 31, 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>time to malignant recurrence</measure>
    <time_frame>from time of operation until time of malignant recurrence, assessed up to 15 years</time_frame>
    <description>recurrence-free survival</description>
  </primary_outcome>
  <primary_outcome>
    <measure>time to death</measure>
    <time_frame>from time of operation until time of death, assessed up to 20 years</time_frame>
    <description>overall survival</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>aspartate aminotrasferase (AST) levels</measure>
    <time_frame>second postoperative day</time_frame>
    <description>aspartate aminotransferase levels</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">230</enrollment>
  <condition>Ischemic Reperfusion Injury</condition>
  <condition>Liver Injury</condition>
  <condition>Cancer Recurrence</condition>
  <condition>Malignancy</condition>
  <condition>Liver Cancer</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <description>patients subjected to major hepatectomy with vascular control of blood inflow and outflow of the whole liver</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>patients subjected to major hepatectomy by selectively clamping the portal and hepatic vessels only of the lobe harboring the tumor</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>selective hepatic vascular exclusion</intervention_name>
    <description>major hepatectomy with vascular control of blood inflow and outflow of the whole liver</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>semielective hepatic vascular exclusion</intervention_name>
    <description>major liver resection by selectively clamping the portal and hepatic vessels only of the lobe harboring the tumor</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        retrospective analysis of an internal hepatectomy database
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients

          -  American Society of Anesthesiologists (ASA) distribution I to III

          -  Patients scheduled for major liver resection (â‰¥3 segments)

        Exclusion Criteria:

          -  patients with extrahepatic disease

          -  patients with metastatic liver tumors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kassiani Theodoraki, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aretaieion University Hospital</affiliation>
  </overall_official>
  <reference>
    <citation>Smyrniotis V, Farantos C, Kostopanagiotou G, Arkadopoulos N. Vascular control during hepatectomy: review of methods and results. World J Surg. 2005 Nov;29(11):1384-96. Review.</citation>
    <PMID>16222453</PMID>
  </reference>
  <reference>
    <citation>Smyrniotis VE, Kostopanagiotou GG, Contis JC, Farantos CI, Voros DC, Kannas DC, Koskinas JS. Selective hepatic vascular exclusion versus Pringle maneuver in major liver resections: prospective study. World J Surg. 2003 Jul;27(7):765-9.</citation>
    <PMID>14509502</PMID>
  </reference>
  <reference>
    <citation>Huang J, Tang W, Hernandez-Alejandro R, Bertens KA, Wu H, Liao M, Li J, Zeng Y. Intermittent hepatic inflow occlusion during partial hepatectomy for hepatocellular carcinoma does not shorten overall survival or increase the likelihood of tumor recurrence. Medicine (Baltimore). 2014 Dec;93(28):e288. doi: 10.1097/MD.0000000000000288.</citation>
    <PMID>25526466</PMID>
  </reference>
  <reference>
    <citation>Liu L, Ren ZG, Shen Y, Zhu XD, Zhang W, Xiong W, Qin Y, Tang ZY. Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: relevance of epithelial-mesenchymal transition. Cancer Sci. 2010 Jan;101(1):120-8. doi: 10.1111/j.1349-7006.2009.01363.x. Epub 2009 Sep 14.</citation>
    <PMID>19832842</PMID>
  </reference>
  <reference>
    <citation>Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg. 2001 Feb;181(2):160-6. Review.</citation>
    <PMID>11425059</PMID>
  </reference>
  <reference>
    <citation>Man K, Ng KT, Lo CM, Ho JW, Sun BS, Sun CK, Lee TK, Poon RT, Fan ST. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways. Liver Transpl. 2007 Dec;13(12):1669-77.</citation>
    <PMID>18044786</PMID>
  </reference>
  <reference>
    <citation>Ozaki M, Todo S. Surgical stress and tumor behavior: impact of ischemia-reperfusion and hepatic resection on tumor progression. Liver Transpl. 2007 Dec;13(12):1623-6.</citation>
    <PMID>18044752</PMID>
  </reference>
  <reference>
    <citation>Cho JY, Han HS, Choi Y, Yoon YS, Kim S, Choi JK, Jang JS, Kwon SU, Kim H. Association of Remnant Liver Ischemia With Early Recurrence and Poor Survival After Liver Resection in Patients With Hepatocellular Carcinoma. JAMA Surg. 2017 Apr 1;152(4):386-392. doi: 10.1001/jamasurg.2016.5040.</citation>
    <PMID>28052154</PMID>
  </reference>
  <reference>
    <citation>Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, Giulini SM. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006 Feb;243(2):229-35.</citation>
    <PMID>16432356</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 2, 2020</study_first_submitted>
  <study_first_submitted_qc>February 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aretaieion University Hospital</investigator_affiliation>
    <investigator_full_name>Dr Kassiani Theodoraki</investigator_full_name>
    <investigator_title>Associate Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>ischemia reperfusion injury</keyword>
  <keyword>liver surgery</keyword>
  <keyword>cancer recurrence</keyword>
  <keyword>malignancy</keyword>
  <keyword>hepatectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Reperfusion Injury</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

